HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.

Mohammad-Rezaei M, Shafaghat Z, Noroozbeygi M, Baig MR, Jasim RA, Smerat A, Fakhri F, Safari E, Jafari R

Open source

DOI
10.1016/j.leukres.2026.108326
Published
2026 Sep 22
Container
Leukemia research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.leukres.2026.108326,
  title = {HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.},
  author = {Mohammad-Rezaei M and Shafaghat Z and Noroozbeygi M and Baig MR and Jasim RA and Smerat A and Fakhri F and Safari E and Jafari R},
  year = {2026},
  journal = {Leukemia research},
  doi = {10.1016/j.leukres.2026.108326},
  url = {https://doi.org/10.1016/j.leukres.2026.108326}
}

RIS

TY  - JOUR
TI  - HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.
AU  - Mohammad-Rezaei M
AU  - Shafaghat Z
AU  - Noroozbeygi M
AU  - Baig MR
AU  - Jasim RA
AU  - Smerat A
AU  - Fakhri F
AU  - Safari E
AU  - Jafari R
PY  - 2026
JO  - Leukemia research
DO  - 10.1016/j.leukres.2026.108326
UR  - https://doi.org/10.1016/j.leukres.2026.108326
ER  - 

APA

M, M., Z, S., M, N., MR, B., RA, J., A, S., F, F., E, S., & R, J. (2026). HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.. Leukemia research. https://doi.org/10.1016/j.leukres.2026.108326

Source records